|
NCL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.182800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.152800E-04 |
| Normal-vs-Stage2 |
8.124100E-03 |
| Normal-vs-Stage3 |
5.713400E-01 |
| Normal-vs-Stage4 |
2.450200E-01 |
| Stage1-vs-Stage2 |
5.457400E-01 |
| Stage1-vs-Stage3 |
2.848000E-02 |
| Stage1-vs-Stage4 |
6.302600E-03 |
| Stage2-vs-Stage3 |
2.170000E-02 |
| Stage2-vs-Stage4 |
7.216300E-03 |
| Stage3-vs-Stage4 |
5.710200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.296720E-03 |
| Normal-vs-AfricanAmerican |
8.749800E-02 |
| Normal-vs-Asian |
6.431600E-01 |
| Caucasian-vs-AfricanAmerican |
5.748000E-01 |
| Caucasian-vs-Asian |
9.575600E-02 |
| AfricanAmerican-vs-Asian |
2.311200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.50029999999424E-05 |
| Normal-vs-Female |
5.150200E-01 |
| Male-vs-Female |
2.560400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.114400E-01 |
| Normal-vs-Extreme_Weight |
1.175620E-04 |
| Normal-vs-Obese |
2.038800E-01 |
| Normal-vs-Extreme_Obese |
1.836290E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.487700E-02 |
| Normal_Weight-vs-Obese |
9.411400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.104600E-01 |
| Extreme_Weight-vs-Obese |
7.256100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.060600E-01 |
| Obese-vs-Extreme_Obese |
2.097800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.200370E-01 |
| Normal-vs-Age(41-60Yrs) |
9.969700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.85880000000061E-05 |
| Normal-vs-Age(81-100Yrs) |
1.068220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.903100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.119400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.765900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.529670E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.345400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.172400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.600700E-04 |
| Normal-VS-Type2 PRCC |
1.356440E-02 |
| Normal-VS-KIRP CIMP |
2.057600E-02 |
| Normal-VS-Unclassified PRCC |
1.512190E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.256000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.244000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.763800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.36999999999599E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
5.548000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.818440E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.187100E-04 |
| Normal-vs-N1 |
3.192300E-02 |
| Normal-vs-N2 |
8.489500E-02 |
| N0-vs-N1 |
5.807300E-04 |
| N0-vs-N2 |
2.108300E-02 |
| N1-vs-N2 |
4.242600E-01 |
|
|
